Info

Actueel

Opsporing uitzaaiingen in de lever verbeterd. lees meer >>

Deelname aan onderzoeksprojecten van het Center for Translational Molecular Medicine (CTMM) blijkt een belangrijke stimulans te bieden aan MKB-bedrijven. lees meer >>

Het topsectorenbeleid een wassen neus? Hoe houden we de gezondheidszorg betaalbaar, van hoogstaande kwaliteit en voor iedereen toegankelijk? lees meer >>

Output boekjes

In het Engels:

If you want to see what 300 million euros of public-private partnership funding can achieve, take a look at the new set of output booklets that have been prepared for the individual CTMM projects.

Scientific breakthroughs, new products, patents, start-up companies, research infrastructures, PhD theses and academic papers, it's all there in black and white - proof that together we have achieved something truly remarkable and placed the Netherlands in a world leading position for translational medical research.

AIRFORCE - personalized chemotherapy against lung cancer

BIOCHIP - Diagnosing leukemia sub-types

Breast CARE - Predicting therapy response in breast cancer patients

DeCoDe - Early diagnosis of colorectal cancer

HIFU-CHEM - More chemo where it should be

MUSIS - Check removal of tumor tissue during surgery

PCMM - Limit over-diagnosis and over-treatment in prostate cancer

VOLTA - Remove tumors through local heating

Circulating Cells - investigating white blood cells and platelets for discriminating patients with increased risk of developing unstable plaques

COHFAR - how to detect and stop ventricular fibrillation by applying a synchronized electrical impulse to heart muscle

Eminence - developing multiple diagnostic technologies to detect neovascularization and stratifying patients

INCOAG - developing a new set of tests to estimate the risk of thrombosis

Parisk - how to predict risk of rupture of an individual plaque

Predicct - focusing on early diagnoses and treatment of Diabetes DM2

Triumph - identifying biomarkers for cardiac failure

LeARN - finding an early diagnosis of Alzheimer's Disease

AmpVacs - a new vaccine technology platform in the combat against conserved influenza A determinants

MARS - tools to provide rapid and accurate information about an individual patient suffering from sepsis

TRACER - patient-tailored treatment of Rheumatoid Arthritis

Health Technology Assessment (HTA)

TraIT - establishing an easy-to-access and easy-to-use infrastructure for sharing of research data, and set of tools for researchers to interact with and explore a unified translational medical research space

March 2018